Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MedinCell
company
About
MedinCell is an injectable slow-release drug specialist company.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €40M
- Industries
- Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 101 - 250
- Operating Status
- Active
MedinCell is an injectable slow-release drug specialist company.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€61M
MedinCell has raised a total of
€61M
in funding over 2 rounds. Their latest funding was raised on
Nov 24, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 24, 2022 | Post-IPO Debt | €40M | 1 |
European Investment Bank
|
— | Detail |
| Dec 1, 2021 | Grant | €1M | 1 |
|
— | Detail |
| Mar 1, 2018 | Debt Financing | €20M | 1 |
European Investment Bank
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
2
MedinCell is funded by 2 investors.
European Investment Bank
and French Recovery Plan
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Post-IPO Debt |
|
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
